13/05/2014 Agilent Technologies Inc. Agilent Technologies Inc. (NYSE: A) today introduced a new ultra-high performance liquid chromatography autosampler, building on the company's industry-leading ...

Antibody–drug conjugates (ADCs) are complex therapeutic biomolecules engineered to specifically target and eliminate cancerous cells while preserving healthy cells. However, the presence of free drug ...

The Agilent high-throughput LC/MS solution is based on the 1290 Infinity II LC system and achieves highest analysis speeds and shortest cycle times without compromising robustness and data quality.

Department of Cardiology, The Affiliated Hospital of Qingdao University, China; Department of Urology, The Affiliated Hospital of Qingdao University, China; ...

ACQUITY UPLC HSS T3 columns (1.8 μm, 2.1 mm × 100 mm, Waters, Dublin, Ireland) were used as the chromatographic column in the Agilent 1290 II UPLC-QTOF 5600 PLUS (Sciex) liquid chromatography-mass ...

1290 Funds lags peer asset managers in a number of stewardship qualities, resulting in a Low Parent Pillar rating. Despite the negative rating, an area of strength of the firm is manager ...

Seamless integration in current infrastructure and smooth method transfer from legacy equipment—for non-disruptive transition to highest productivity and lowest cost of ownership. The ...

13/11/2012 Agilent Technologies Inc. SANTA CLARA, Calif., Nov. 12, 2012 - Agilent Technologies Inc. (NYSE: A) today announced two new products-۠the 1290 Infinity Evaporative Light-Scattering ...